Jan 15, 2026 06:45AM
Jan 6, 2026 02:26PM
Dec 15, 2025 08:45AM
Sep 23, 2025 06:37AM
Sep 22, 2025 08:45AM
Aug 26, 2025 01:08AM
Aug 6, 2025 08:45AM Actuate Therapeutics starts pancreatic cancer trial with Incyte, Pittsburgh
Jul 25, 2025 04:03PM
Jul 21, 2025 06:46AM
Jun 20, 2025 08:45AM
May 22, 2025 05:29PM
May 6, 2025 08:01AM
Apr 22, 2025 09:02AM
Feb 25, 2025 08:04AM Actuate Therapeutics (ACTU) Announces Completion of Enrollment in a Phase 2 Trial of Elraglusib in Combination with FOLFIRINOX and Losartan in Patients with Previously Untreated Metastatic Pancreatic
Jan 7, 2025 08:03AM
Dec 17, 2024 08:02AM
Nov 12, 2024 08:04AM
Sep 11, 2024 08:00AM
Sep 9, 2024 08:01AM
Jul 23, 2024 06:07AM
Jul 19, 2024 08:00AM Actuate Therapeutics (ACTU) Files for 2.78M Share Offering by Selling Stockholders
Jun 11, 2024 07:04AM

341,965 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All